Noninvasive fetalRHDgenotyping of RhD negative pregnant women for targeted anti-D therapy in Australia: A cost-effectiveness analysis

Author:

Gordon Louisa G.12ORCID,Hyland Catherine A.3,Hyett Jonathan A.4,O'Brien Helen3,Millard Glenda3,Flower Robert L.3,Gardener Glenn J.5

Affiliation:

1. QIMR Berghofer Medical Research Institute; Population Health Department; Brisbane Australia

2. Queensland University of Technology; School of Nursing; Brisbane Australia

3. Australian Red Cross Blood Service; Brisbane Australia

4. Clinical Professor and Head of High Risk Obstetrics, RPA Women and Babies; Royal Prince Alfred Hospital; Sydney Australia

5. Centre for Maternal Fetal Medicine at Mater Mothers' Hospitals; Brisbane Australia

Funder

Australian Red Cross Blood Service

Publisher

Wiley

Subject

Genetics (clinical),Obstetrics and Gynecology

Reference37 articles.

1. Report of the first nationally implemented clinical routine screening for fetal RHD in D- pregnant women to ascertain the requirement for antenatal RhD prophylaxis;Clausen;Transfusion,2012

2. A nation-wide fetal RHD screening programme for targeted antenatal and postnatal anti-D;Haas;ISBT Sci Ser,2012

3. Evaluation of non-invasive prenatal RHD genotyping of the fetus;Hyland;Med J Austr,2009

4. The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis;Mackie;BJOG: Internat J Obstetr Gynaecol,2016

5. Impact of non-invasive fetal RhD genotyping on management costs of rhesus-D negative patients: results of a French pilot study;Benachi;Eur J Obstetr, Gynecol, Reproduct Biol,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3